Side effects – a thing of the past….?

European Biotechnology Magazine

Summer Edition, Drug Safety, Vol. 18, 2019

Side effects – a thing of the past….? Despite large investments into drug safety, the pharma industry still loose hundreds of billions by safety-related attrition. Our Senior Vice President Drug Discovery Dr. Torsten Hoffmann was recently interviewed by the European Biotechnology Magazine.

Want to know more about this publication?

Contact our scientists

medicinal chemistry

Drug Discovery

Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular…

performance chemicals

Material Science

We create performance chemicals to enhance new materials, plastics, coatings, dyes & inks, cosmetics, flavors and many more research and industrial applications…


Looks interesting?

As a leading contract research organization in discovery chemistry and custom synthesis, Taros provides comprehensive solutions to meet our clients’ needs from diverse branches and applications

Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.